Summary of the HTA, funding and innovation payment landscape for gastrointestinal technologies in Europe

17

Oct 2019

MTRC has developed three reports on the key market access topics, including innovation funding, health technology assessment and funding frameworks for medical devices. These reports help to understand the relevance of these frameworks to certain types of medical technologies, including gastrointestinal technologies.

Did you know that:

  • There were 6 health technology assessments of gastrointestinal technologies in 2018 in Europe;
  • These assessments were published only in 3 EU countries;
  • Only 1 assessment was published by the regional HTA bodies, the remaining were published by the national organizations;
  • There were 19 funding decisions about gastrointestinal technologies published in 3 EU with established funding frameworks countries for all time periods;
  • In 63% of the cases, funding decisions were positive in relation to gastrointestinal technologies;
  • There was 1 positive innovation funding decisions (NUB) for gastrointestinal in Germany in 2019.

By accessing one or several of our syndicated reports you can:

  • Understand the relevance of topics of innovation funding, health technology assessment and funding frameworks in the gastrointestinal field;
  • Understand, which countries are more active with HTA, funding and innovation funding for gastrointestinal devices;
  • Understand, what types of technologies typically triggers HTA or review by the funding authorities / decision-makers;
  • Understand, what gastrointestinal technologies got positive and negative funding decisions;
  • Develop fact-based market access strategies for your portfolio of devices;
  • Prioritize markets, based on the solid information about HTA and reimbursement activity for your type of product.

You can get access either to the full reports or limited to the topic of gastrointestinal devices. Download sample pages of the reports via the links provided above.

Contact us at info@mtrconsult.com to request a quote or get more information.

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more